Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 478,600 | 341,300 | 249,700 | 154,500 | 89,600 |
| Depreciation Amortization | 17,400 | 900 | 3,000 | 19,300 | 35,600 |
| Income taxes - deferred | 165,400 | -123,100 | -56,700 | 19,100 | 4,300 |
| Accounts receivable | -210,500 | -39,800 | -89,300 | -162,200 | -28,400 |
| Other Working Capital | -128,800 | -19,200 | 28,200 | -67,400 | 16,700 |
| Other Operating Activity | 460,600 | 435,300 | 255,000 | 376,100 | 138,700 |
| Operating Cash Flow | $782,700 | $595,400 | $389,900 | $339,400 | $256,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,319,800 | -1,056,100 | -1,379,900 | -621,200 | -102,200 |
| PPE Investments | -34,000 | -38,200 | -28,300 | -16,500 | -23,400 |
| Net Acquisitions | N/A | N/A | N/A | -42,700 | N/A |
| Purchase Of Investment | N/A | N/A | -31,300 | -7,700 | -4,600 |
| Sale Of Investment | 1,089,400 | 967,500 | 972,400 | 511,000 | N/A |
| Investing Cash Flow | $-264,400 | $-126,800 | $-467,100 | $-177,100 | $-130,200 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -308,800 | N/A | -279,000 | -100 |
| Common Stock Issued | 129,400 | 122,100 | 65,300 | 44,700 | 27,500 |
| Common Stock Repurchased | -167,700 | -300,000 | N/A | N/A | N/A |
| Financing Cash Flow | $-38,300 | $-486,700 | $65,300 | $-234,300 | $27,400 |
| Exchange Rate Effect | N/A | N/A | 300 | -1,300 | N/A |
| Beginning Cash Position | 241,000 | 259,100 | 270,700 | 344,000 | 190,300 |
| End Cash Position | 721,000 | 241,000 | 259,100 | 270,700 | 344,000 |
| Net Cash Flow | $480,000 | $-18,100 | $-11,600 | $-73,300 | $153,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | 782,700 | 595,400 | 389,900 | 339,400 | 256,500 |
| Capital Expenditure | -34,000 | -38,200 | -28,300 | -16,500 | -23,400 |
| Free Cash Flow | 748,700 | 557,200 | 361,600 | 322,900 | 233,100 |